BioScript Solutions Welcomes New Chief Executive Officer
Dear Valued Partner,
We are very excited to welcome Lisa Matar as BioScript Solutions’ newly appointed Chief Executive Officer. In the role of CEO, Lisa will lead the strategic and operational direction of BioScript.
Lisa’s professional experience and personal commitment to the healthcare industry clearly solidified her as the best fit for our organization. We are confident that Lisa’s guidance will accelerate us into the future and allow us to continue to simplify access to specialty care for even more Canadians.
Meet Lisa Matar
Lisa Matar is a Global Life Science executive with more than 25 years of experience leading organizations and driving significant growth, profitability, and launching excellence across the globe.
During her 25-year career with Eli Lilly, she has held various senior roles in marketing, sales and general management. Her extensive experience covers a variety of therapeutic areas such oncology, diabetes, cardiology and auto immunes in both Europe and Canada.
She has served as President and General Manager of Eli Lilly Canada from 2013 to 2020. In that role, she led major business transformations in support of the launch of the company’s specialty portfolio. During her tenure in Canada, Lisa has been named to the Board of Directors of Innovative Medicines Canada (IMC).
Lisa has most recently worked with early and growth-stage Biotech startups in the oncology field, focusing on overall strategy and commercialization to maximize speed to market. Lisa currently serves on the board of Directors of Delphi Diagnostics TM, Inc. and Starpax Biopharma.
Lisa graduated with a Doctorate in Pharmacy from St Joseph University, Lebanon.
“BioScript Solutions is a truly unique company with an exciting future, and I am thrilled to have the opportunity to lead the company’s growth journey. It is a privilege and an honour to work with such a dynamic and passionate team as we continue to deliver best-in-class service solutions for specialty care. I look forward to playing a part in the BioScript Solutions story.”
— Lisa Matar
We thank you for your continued partnership and look forward to the impact Lisa will have on our commitment to providing the best possible service to you, and to the patients we serve together.
We couldn’t be more thrilled to welcome Lisa to our team!
Sincerely,
David Ford and Andrew Steeves, Co-Founders
David Ford and Andrew Steeves, Co-Founders